DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity

Alvaro Lladser*, Dimitrios Mougiakakos, Helena Tufvesson, Maarten A. Ligtenberg, Andrew F.G. Quest, Rolf Kiessling, Karl Ljungberg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity'. Together they form a unique fingerprint.

Immunology and Microbiology